What is "vayarin"

Vayarin is a prescription medical food for the clinical dietary management of certain lipid imbalances claimed to be associated with attention deficit hyperactivity disorder (ADHD) in children. Vayarin contains Lipirinen, a proprietary composition containing phosphatidylserine- omega 3, EPA ( Eicosapentaenoic acid) enriched. Vayarin was developed by VAYA Pharma (a division of Enzymotec LTD), a specialty pharmaceutical company not currently registered with the US FDA as a pharmaceutical manufacturer. Vayarin represents a new approach to helping manage attention deficit hyperactivity disorder symptoms in children. It is a medical food regulated by the U.S. Food and Drug Administration (FDA) under the Orphan Drug Act and is intended for the distinct nutritional requirements of children under a physician’s supervision and by prescription only. The Orphan Drug Act does not require that medical foods be recommended for use by prescription. Neither Enzymotec nor VAYA Pharma have received a determination that Vayarin is in fact a medical food.